Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Pediatrics · Congenital Nephrotic Syndrome

Does Congenital Nephrotic Syndrome Cause Brain Damage?

At a Glance

Congenital nephrotic syndrome does not inherently cause brain damage or cognitive delays. The underlying genetic mutation primarily affects the kidneys. However, severe protein loss can cause secondary thyroid hormone deficiency, which must be treated to protect a baby's developing brain.

When your child is diagnosed with Congenital Nephrotic Syndrome of the Finnish type (CNF), the severe swelling (edema) and immediate medical crisis are terrifying. It is completely natural to worry that such a severe illness might cause permanent brain damage or learning delays. The short answer is no: the genetic mutation that causes CNF does not inherently damage the brain, and with vigilant medical care, most children go on to have normal cognitive and neurodevelopmental outcomes after a kidney transplant.

The Genetics: Why the Brain is Spared

The Finnish type of congenital nephrotic syndrome is caused by a mutation in the NPHS1 gene [1]. This gene provides the instructions for making a protein called nephrin [2]. While nephrin is present in the central nervous system, its primary and most critical role is acting as a building block in the kidneys’ filtering units (podocytes) [3].

Because nephrin’s vital mechanical function is centered in the kidney filters, the NPHS1 mutation’s clinical effects are overwhelmingly focused on the kidneys. The mutation does not directly cause structural brain damage [2]. Your child’s brain structure and underlying cognitive potential are intact.

The Crucial Role of the Thyroid

While the genetic mutation does not hurt the brain, the massive leakage of protein into the urine can cause a secondary issue that parents must know about: the loss of thyroid hormones [4].

Because your baby is losing so much protein, they also lose thyroid-binding globulin (TBG), the protein that carries thyroid hormone through the blood [5]. Thyroid hormones are absolutely essential for a baby’s early brain development. If this loss goes unrecognized, it can lead to secondary hypothyroidism, which can cause cognitive delays [6]. To prevent this, your child’s medical team will aggressively monitor their thyroid levels and will likely prescribe a daily thyroid hormone replacement to fully protect their developing brain [4].

Early Delays: Physical, Not Cognitive

In the first few years of life, you might notice that your baby is behind on certain milestones, like sitting up, crawling, or walking. It is important to know that these are usually physical or motor delays, not cognitive ones.

Infants with CNF spend a lot of time in the hospital, undergo multiple medical procedures, and carry excess fluid weight due to severe swelling [7]. Being sick and hospitalized simply gives them less opportunity to practice physical skills. Additionally, managing heavy swelling makes movement physically difficult.

Even after a kidney transplant, some children might experience slightly reduced physical performance compared to healthy peers, but this is a result of their long medical journey and physical strain, not a brain injury [8]. Many parents find it helpful to ask their care team about early intervention programs and pediatric physical therapy, which can provide targeted exercises to help their child build muscle and reach motor milestones.

Rare Risks to Watch For

The severe loss of protein in the urine can lead to another secondary complication. Children with nephrotic syndrome lose proteins that help balance blood clotting, putting them in a hypercoagulable state (a condition where the blood clots too easily) [9].

Rarely, this can lead to a condition called cerebral sinovenous thrombosis (CSVT), which is a blood clot in the brain [10]. A clot like this can cause neurological damage if not caught early [11]. This is why your child’s medical team carefully monitors their fluid balance, nutrition, and blood chemistry to prevent complications [7]. For a hospitalized baby who is already tired, warning signs can be hard to spot, but look out for a bulging soft spot (fontanelle) on the top of the head, inconsolable or high-pitched crying, or sudden, extreme changes like abnormal eye movements or seizures. If you notice these, alert a doctor immediately.

The Post-Transplant Future and Medications

The early years of managing CNF are intensely difficult, often requiring dialysis or a kidney transplant. However, studies looking at the long-term outcomes of children who undergo kidney transplantation for CNF show that they have favorable, satisfactory long-term development [12].

Once they receive a working kidney and their body is no longer constantly battling fluid imbalance, children experience significant developmental “catch-up.” This catch-up process typically unfolds over the months and years following the transplant.

It is true that after the transplant, your child will need lifelong immunosuppressant medications (such as tacrolimus or cyclosporine) to prevent their body from rejecting the new kidney. These medications can sometimes cause neurological side effects, such as mild tremors or headaches [13][14]. However, your care team will carefully monitor and adjust the medication doses to minimize these effects [15]. These life-saving drugs will not prevent your child from achieving normal intelligence; rather, the working kidney they protect is what allows your child to learn, grow, and thrive alongside their peers.

Common questions in this guide

Will the NPHS1 gene mutation cause permanent brain damage in my child?
No, the NPHS1 mutation associated with Finnish type congenital nephrotic syndrome primarily affects the kidneys' filtering units. The genetic mutation itself does not cause structural brain damage or inherently lower your child's cognitive potential.
Why does my baby with congenital nephrotic syndrome need their thyroid checked?
Babies with severe nephrotic syndrome lose massive amounts of protein in their urine, including the proteins that carry thyroid hormones. Because thyroid hormones are essential for early brain development, doctors closely monitor and replace these hormones to prevent cognitive delays.
Why is my baby delayed in sitting up and walking?
Delays in physical milestones like sitting or walking are common due to severe swelling, frequent hospitalizations, and overall fatigue. These are physical and motor delays rather than cognitive issues, and many children catch up with the help of pediatric physical therapy.
What are the warning signs of a blood clot in the brain for an infant with CNF?
Because they lose proteins that balance blood clotting, infants with CNF are at risk for blood clots. Warning signs of a brain blood clot include a bulging soft spot on the head, inconsolable or high-pitched crying, abnormal eye movements, or seizures, requiring immediate medical attention.
Will my child be able to learn and develop normally after a kidney transplant?
Yes, studies show that children who receive a successful kidney transplant for congenital nephrotic syndrome generally have normal long-term neurodevelopment. Once the body is no longer battling severe fluid imbalance, children often experience a significant developmental catch-up.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How often are my child's thyroid levels (TSH and free T4) being checked, and do we need to start thyroid hormone replacement?
  2. 2.What specific signs of blood clots (CSVT) should I look out for, especially when my baby is already tired or resting?
  3. 3.Can we get a referral for early intervention or pediatric physical therapy to help my baby practice their motor skills?
  4. 4.What preventative measures are we taking to protect against blood clots while my child's protein levels are critically low?
  5. 5.As we prepare for a future kidney transplant, how will we monitor and adjust my child's immunosuppressant doses to minimize side effects like tremors?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (15)
  1. 1

    A Case of Congenital Nephrotic Syndrome with Crescents Caused by a Novel Compound Heterozygous Pairing of NPHS1 Genetic Variants.

    Goodman KN, Puapatanakul P, Barton KT, et al.

    Case reports in nephrology 2024; (2024()):5121375 doi:10.1155/2024/5121375.

    PMID: 38444459
  2. 2

    Phenotypic quantification of Nphs1-deficient mice.

    Schneider R, Mansour B, Kolvenbach CM, et al.

    Journal of nephrology 2025; (38(1)):143-152 doi:10.1007/s40620-024-01987-8.

    PMID: 39003671
  3. 3

    Nephrinuria and podocytopathies.

    Kostovska I, Trajkovska KT, Topuzovska S, et al.

    Advances in clinical chemistry 2022; (108()):1-36 doi:10.1016/bs.acc.2021.08.001.

    PMID: 35659057
  4. 4

    Urinary loss of thyroid hormones: An issue to remember.

    Capel I, Betancourt L, Luchtenberg MF, et al.

    Endocrinologia, diabetes y nutricion 2023; (70(10)):649-653 doi:10.1016/j.endien.2023.11.011.

    PMID: 38065629
  5. 5

    Case Report: A Toddler With Anasarca Caused by Congenital Nephrotic Syndrome.

    Satekge TM, Kiabilua O, van Biljon G, et al.

    EJIFCC 2017; (28(2)):156-163.

    PMID: 28860961
  6. 6

    It's Not Lupus This Time! A Case of Worsening Hypothyroidism in a Patient With Nephrotic Syndrome.

    Iqbal S, Wan WY, Mitchell NE

    Cureus 2022; (14(5)):e25355 doi:10.7759/cureus.25355.

    PMID: 35761923
  7. 7

    Management of congenital nephrotic syndrome: consensus recommendations of the ERKNet-ESPN Working Group.

    Boyer O, Schaefer F, Haffner D, et al.

    Nature reviews. Nephrology 2021; (17(4)):277-289 doi:10.1038/s41581-020-00384-1.

    PMID: 33514942
  8. 8

    Physical performance capacity after pediatric kidney transplant and clinical parameters associated with physical performance capacity.

    Mäenpää H, Tainio J, Arokoski J, Jahnukainen T

    Pediatric nephrology (Berlin, Germany) 2023; (38(5)):1633-1642 doi:10.1007/s00467-022-05758-0.

    PMID: 36315277
  9. 9

    Cerebral sinovenous thrombosis in children with nephrotic syndrome: systematic review and one new case.

    Konopásek P, Piteková B, Krejčová V, Zieg J

    Frontiers in pediatrics 2023; (11()):1207871 doi:10.3389/fped.2023.1207871.

    PMID: 37691772
  10. 10

    Perinatal Stroke and Cerebral Sinovenous Thrombosis Caused by Congenital Nephrotic Syndrome NPSH1 (Finnish Type): A Case Report.

    Oldenmark BOV, Wintjens VEHJ, Toirkens MJP, et al.

    Neuropediatrics 2025; (56(6)):412-416 doi:10.1055/a-2655-9135.

    PMID: 40669863
  11. 11

    Perinatal arterial ischemic stroke (PAIS) and neonatal cerebral sinovenous thrombosis (CSVT) in the preterm neonate: a systematic review.

    van Oldenmark BO, van Steenis A, van der Aa NE, et al.

    Pediatric research 2026; doi:10.1038/s41390-026-04800-3.

    PMID: 41680509
  12. 12

    Long-term outcome of congenital nephrotic syndrome after kidney transplantation in Japan.

    Hamasaki Y, Muramatsu M, Hamada R, et al.

    Clinical and experimental nephrology 2018; (22(3)):719-726 doi:10.1007/s10157-017-1508-4.

    PMID: 29185126
  13. 13

    Tremor induced by Calcineurin inhibitor immunosuppression: a single-centre observational study in kidney transplanted patients.

    Erro R, Bacchin R, Magrinelli F, et al.

    Journal of neurology 2018; (265(7)):1676-1683 doi:10.1007/s00415-018-8904-x.

    PMID: 29777361
  14. 14

    Neurologic Complications of Solid Organ Transplantation.

    Pizzi M, Ng L

    Neurologic clinics 2017; (35(4)):809-823 doi:10.1016/j.ncl.2017.06.013.

    PMID: 28962815
  15. 15

    Immunosuppressants in Organ Transplantation.

    Tönshoff B

    Handbook of experimental pharmacology 2020; (261()):441-469 doi:10.1007/164_2019_331.

    PMID: 31820175

This page is for informational purposes only and does not replace professional medical advice. Always consult your pediatric nephrologist or care team regarding your child's specific development and treatment plan.

Get notified when new evidence is published on Congenital nephrotic syndrome, Finnish type.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.